Company Valuation: IntegraGen

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020
Market Cap 1 6.536 13.61
Change - 108.2%
Enterprise Value (EV) 1 4.017 10.5
Change - 161.33%
P/E -23x -36.6x
PBR 2.61x 6.28x
PEG - -1.3x
Capitalization / Revenue 0.79x 1.51x
EV / Revenue 0.49x 1.17x
EV / EBITDA -37.6x -375x
EV / EBIT -11.1x -41.2x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 -0.0439 -0.0559
Distribution rate - -
Net sales 1 8.28 9
EBITDA 1 -0.107 -0.028
EBIT 1 -0.3631 -0.255
Net income 1 -0.2848 -0.375
Net Debt 1 -2.519 -3.109
Reference price 2 1.0100 2.0500
Nbr of stocks (in thousands) 6,471 6,638
Announcement Date 4/3/20 6/11/21
1EUR in Million2EUR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 554K
16.04x6.01x11.53x1.86% 60.57B
38x6.73x20.1x0.85% 55.51B
29.64x7.94x26.66x0.05% 55.22B
34.27x3.27x14.1x-.--% 43.27B
46.82x5.37x29.4x-.--% 40.36B
-20.16x195.48x-21.51x-.--% 41.63B
45.18x8.03x26.9x-.--% 33.29B
31.71x8.03x20.88x0.41% 32.27B
-65.46x12.04x-67.36x-.--% 22.91B
Average 17.34x 28.10x 6.74x 0.35% 38.5B
Weighted average by Cap. 21.50x 27.20x 10.94x 0.46%

Y-o-Y evolution of P/E

Valuation ratios - P/E - IntegraGen

Historical PBR trend

Valuation ratios - PBR - IntegraGen

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - IntegraGen

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - IntegraGen